| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
GT Biopharma, Inc.
13G/A
GTBP · 36254L308
|
9.8% |
10/17/2024
Event 9/30/2024
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.